CBK:CRYPTOCAPMarket Cap CBK, $ Analysis
Data as of 2026-03-15 - not real-time
$25.01
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Commercial Bancgroup (CBK) trades at a trailing PE of 8.6, well below the industry average of 16.4, indicating a potentially undervalued position. The stock sits above its 20‑day (26.01) and 50‑day (25.69) SMAs, with the 20‑day SMA also above the 200‑day SMA (25.06), suggesting a bullish medium‑term trend. However, the MACD histogram is negative and the RSI sits at 38.4, pointing to short‑term momentum weakness. Volatility over the past 30 days is elevated at roughly 22%, but the beta of 0.47 signals lower sensitivity to broader market moves. The dividend yield is modest at 0.4% with a zero payout ratio, implying the current payout is easily sustainable. Analysts project an upside of about 32% to a target price of $33, driven by solid operating margins (55%) and a healthy ROE of 14.6%.
Liquidity is modest, with decreasing volume and an average 10‑day volume of ~35k shares, while the support level at $24.56 and resistance at $27.20 frame the near‑term price range. The company’s balance sheet shows more cash ($144M) than debt ($167M) and a low debt‑to‑equity ratio, reducing financial risk. Regional banking exposure adds medium sector and regulatory risk, but the geographic focus on the U.S. keeps currency risk low. Overall, CBK presents a value‑oriented play with upside potential, tempered by short‑term technical softness and modest liquidity.
Liquidity is modest, with decreasing volume and an average 10‑day volume of ~35k shares, while the support level at $24.56 and resistance at $27.20 frame the near‑term price range. The company’s balance sheet shows more cash ($144M) than debt ($167M) and a low debt‑to‑equity ratio, reducing financial risk. Regional banking exposure adds medium sector and regulatory risk, but the geographic focus on the U.S. keeps currency risk low. Overall, CBK presents a value‑oriented play with upside potential, tempered by short‑term technical softness and modest liquidity.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near recent support level
- Bearish MACD histogram
- Decreasing trading volume
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Significant upside potential to $33 target
- Undervalued PE relative to peers
- Strong operating margins and ROE
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Stable cash‑rich balance sheet
- Sustainable dividend despite low yield
- Low beta indicating defensive characteristics
Key Metrics & Analysis
Financial Health
Revenue Growth2.50%
Profit Margin40.95%
P/E Ratio8.6
ROE14.62%
ROA1.61%
P/B Ratio1.2
Industry P/E16.4
Technical Analysis
TrendBullish
RSI38.4
Support$24.56
Resistance$27.20
MA 20$26.01
MA 50$25.69
MA 200$25.06
MACDBearish
VolumeDecreasing
Fear & Greed Index72.88
Valuation
Target Price$33.00
Upside/Downside31.95%
GradeUndervalued
TypeValue
Dividend Yield0.40%
Risk Assessment
Beta0.47
Volatility22.00%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.